ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial
-
Published:2023-10
Issue:
Volume:1
Page:3-8
-
ISSN:2949-8198
-
Container-title:ESMO Gastrointestinal Oncology
-
language:en
-
Short-container-title:ESMO Gastrointestinal Oncology
Author:
Lee J.ORCID, Dean A., Price T.ORCID, Sjoquist K.ORCID, Gebski V., Mumford J., Day F.ORCID, Yip S., Wilson K.ORCID, Jackson C.ORCID, Padinharakam S., Lee B.ORCID, Burge M., Siu D.ORCID, Karapetis C.ORCID, Chantrill L., Wong Z.W.ORCID, Jennens R., Lomma C., Franscesconi A., Ackland S.ORCID, Lynam J.ORCID, Wahlroos S.ORCID, So J., Jameson M.ORCID, Tebbutt N.ORCID, Gill S., Grimes D., Steer C.ORCID, Harris M.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|